{
    "code": 0,
    "data": [
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Marksans Pharma Limited submits transcript of Investors/Analyst meet on Q3 9M FY 26 Unaudited Financial Results held on February 06 2026",
            "news_id": "9dcd5d01-6cf6-40ce-ac97-3ef7a828e2bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebecc4ff-caba-46d7-bfc8-af5f501d091f.pdf",
            "news_date": "2026-02-12 16:03:22",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of investor(s) / analyst(s) meet Conference Call on Q3 & 9M FY26 Financial Results",
            "news_id": "8efd18cc-1f65-40be-b0b2-0921369cfa40",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0af9e3cc-f480-4488-ac3c-c7925b56faaa.pdf",
            "news_date": "2026-02-06 18:25:54",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Marksans Investors Presentation Q3 and 9M FY 26",
            "news_id": "54d915a4-e2aa-468e-8c39-b0c372f0464e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06ee0731-fe61-4466-9013-15e76d05ed7b.pdf",
            "news_date": "2026-02-05 13:57:15",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended 31 December 2025",
            "news_body": "Unaudited financial results for the quarter and nine months ended 31 December 2025",
            "news_id": "d7f0bcdc-94c3-420b-94e6-99a50d27d638",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=886eea3a-1634-4e4d-a3dd-0c495902a4b7.pdf",
            "news_date": "2026-02-05 13:44:00",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording upload intimation with respect to investors /analysts meet regarding Q2 FY26 unaudited financial results",
            "news_id": "b719eb7c-e9a9-4aad-a98d-64f83308b701",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9debd3e1-3efd-4d2b-832f-e88e6d24083f.pdf",
            "news_date": "2025-11-14 19:56:34",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Marksans Pharma Limited Investor Presentation for Q2 FY26",
            "news_id": "580b2f8e-05ec-4663-9367-af71f92750e6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=561963c2-f7bd-403c-8ef9-fe5811634512.pdf",
            "news_date": "2025-11-13 19:42:16",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30 September 2025",
            "news_body": "Unaudited Financial Results both standalone and consolidated for the quarter and half year ended 30 September 2025",
            "news_id": "6d2e70fc-5987-44cf-949e-d30597e575c3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b17921f2-848b-43b5-b5dc-6ce569651876.pdf",
            "news_date": "2025-11-13 19:38:46",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call transcript for Q1 FY 26.",
            "news_id": "029fa670-1dbc-4b29-94b8-87b523ad9389",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ce04a0c-323d-435b-9e1c-36e0c80b2242.pdf",
            "news_date": "2025-08-19 10:52:19",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Analyst/ Investor meet audio recording",
            "news_id": "d2b97854-2a40-47c2-ba11-ee9af796102e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f0e8f16-4a38-474a-8048-739383fa268e.pdf",
            "news_date": "2025-08-13 19:13:59",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Quarter Ended June 30 2025",
            "news_body": "The Board in its meeting considered and adopted Financial Results for the Quarter ended June 30 2025.",
            "news_id": "5a730a10-be40-4e24-85f1-dd66a0a323ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6715072-2e02-4ab4-bc98-82772576b9eb.pdf",
            "news_date": "2025-08-12 13:46:11",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation of Q1 FY 26",
            "news_id": "be1380d1-c398-4947-bc01-b08a88dd5374",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7449f75b-f499-4f5c-a133-db74f1549d81.pdf",
            "news_date": "2025-08-12 13:22:16",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform the stock exchanges that the Company has uploaded the audio recording of investor(s) / analyst(s) meet for Q4FY25 financial performance and strategy update held today i.e. May 20 2025 on the Companys website at http://marksanspharma.com/investors-meet.html",
            "news_id": "89c28192-8bd4-4f99-8a20-cfbb081b525d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d85a0812-8eb9-4f90-afa8-eb2b8693a88f.pdf",
            "news_date": "2025-05-20 21:00:18",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Results For The Year Ended March 31 2025",
            "news_body": "Standalone and Consolidated results for the year ended March 31 2025",
            "news_id": "8143d6dc-726d-48b4-9eb2-032ea1d8a90e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba3fcba1-d8ae-4f48-ae08-cefeb491cdc0.pdf",
            "news_date": "2025-05-19 22:04:08",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation attached",
            "news_id": "0154caf0-ba3d-48ad-9e94-5263bce4dddd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3ccd2d1-b84e-4cba-82bd-0082038c7d29.pdf",
            "news_date": "2025-05-19 20:40:14",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Kindly find enclosed",
            "news_id": "1941edc9-6c5b-4e29-b874-2924a31b465f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de9e78c7-d9a6-47b3-99fb-3024051aaec2.pdf",
            "news_date": "2025-02-25 12:08:52",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Kindly find enclosed",
            "news_id": "860974fc-baed-408e-9edf-d73a6fa0ca35",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3a9c046-2eec-42a4-af77-ed6caa22efd3.pdf",
            "news_date": "2025-02-25 12:03:56",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter And Nine Months Ended December 31 2024",
            "news_body": "Kindly find enclosed",
            "news_id": "7128ab42-ad9e-4fbb-8e15-cd86c9e8cb72",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac54d7f2-a381-4c74-89a4-fb173e8de227.pdf",
            "news_date": "2025-02-11 20:53:22",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Kindly find enclosed investor presentation",
            "news_id": "d25fa182-3ae9-475a-a946-f19e6151f897",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c3e40b8-5740-4fae-be66-d0d040b09b93.pdf",
            "news_date": "2025-02-11 20:46:32",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Kindly find enclosed earnings call transcript for Q2FY25 financial performance and strategy update",
            "news_id": "5a71316e-c52d-40cb-9300-9cf3ebe6b75f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25a27757-30ac-4034-ac29-1c4f9596f2c6.pdf",
            "news_date": "2024-11-25 10:34:46",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter And Half Year Ended September 30, 2024",
            "news_body": "Kindly find enclosed",
            "news_id": "40a6f7ae-c89b-4592-a4ca-b373326e7c87",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95a8d751-081a-4ca9-a055-b69d10aecddb.pdf",
            "news_date": "2024-11-12 13:12:28",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "PFA",
            "news_id": "cfcb4104-f968-4dad-aec9-b1f32be0a796",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=421eca1a-2738-45e2-b849-1fa434718354.pdf",
            "news_date": "2024-11-12 13:04:40",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Kindly find encloed",
            "news_id": "89a8ecf7-637b-480d-b154-bc84324316bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb086858-4995-41a6-adf5-d076c0535e71.pdf",
            "news_date": "2024-08-22 14:24:35",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Kindly find enclosed",
            "news_id": "b41fb742-955a-4b0e-a347-4000da44000a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52a65efa-c5b2-4cea-b4c8-af52a2d2dcb7.pdf",
            "news_date": "2024-08-13 19:58:27",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result For Quarter Ended June 30, 2024",
            "news_body": "Kindly find enclosed",
            "news_id": "6e5ff8ee-4e69-4582-83cb-5696ec8c62e0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fb74909-d5a1-4434-8554-54d08cbac240.pdf",
            "news_date": "2024-08-13 19:55:11",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Kindly find attached transcript of earnings call Q4FY24",
            "news_id": "3d60e361-5e26-4bde-9b9d-e8c102832dd8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e63d207-a628-43f3-b3ad-49088a4242ca.pdf",
            "news_date": "2024-06-05 17:24:56",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on financial results for FY24",
            "news_id": "626a7e49-a1d5-41ad-a07b-850dce3641cd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f11415cc-06c3-4ce6-a99f-d7cd31980047.pdf",
            "news_date": "2024-05-30 12:08:45",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For FY24",
            "news_body": "Kindly find enclosed the results for FY24",
            "news_id": "74b2809f-071e-493d-8e53-320f16d6d16e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63997228-0914-401a-a72e-24d4c7728857.pdf",
            "news_date": "2024-05-30 12:05:47",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Kindly find enclosed the transcript of investors/analysts meet for Q3FY24 financial performance",
            "news_id": "10d88ced-8a3b-4abb-89d7-7b97d30a87c6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=759b003c-c3fe-4e50-a2df-cb8d111c7e8b.pdf",
            "news_date": "2024-02-20 14:30:30",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording link of investors/analysts meet fir Q3FY24",
            "news_id": "2333f2be-9f9b-4f91-a719-e45db5bc0cb6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7aeb6f7-8d24-4d02-b4fe-bfa6381eb42e.pdf",
            "news_date": "2024-02-14 18:26:40",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Quarterly Financial Results For Quarter Ended December 31, 2023",
            "news_body": "Quarterly financial results for quarter ended December 31, 2023",
            "news_id": "51c1004e-dcd7-452b-aa0c-666e34478e26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=120f7fbb-d008-4d87-8fca-4d2124703641.pdf",
            "news_date": "2024-02-13 14:51:27",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation on financial results for quarter ended December 31, 2024",
            "news_id": "5dc45b25-b2c6-4f6e-9e40-1f197cd42ac8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84758428-9feb-4bea-84ca-a2a18c5eb159.pdf",
            "news_date": "2024-02-13 14:40:32",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to regulation 30, please find enclosed the transcript of the investors / analysts meet for Q2FY2024 held on November 09, 2023",
            "news_id": "324b6ced-86bd-46d9-b1a5-dfa399891d43",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c84979e4-afdd-4054-9077-8f9413709883.pdf",
            "news_date": "2023-11-16 12:25:17",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to regulation 30 of SEBI (LODR) regulations, 2015, the Company has uploaded the audio recording of investors/analysts meet for Q2FY24 financial performance and strategy update held today i.e. November 09, 2023 on the Company website",
            "news_id": "f2b8f48a-69a5-4d13-8c9d-ab49b3ff2e9e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ddab8503-2adb-4c89-953d-8500f33817b0.pdf",
            "news_date": "2023-11-09 19:28:38",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Quarterly And Half Yearly Results For Period Ended September 30, 2023",
            "news_body": "Quarterly and half yearly results",
            "news_id": "4b4e59a3-4459-4fa3-9a97-d15451d0d48e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d644caa9-2a2f-491d-83d2-8d77ebde25a2.pdf",
            "news_date": "2023-11-09 13:29:26",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation for Q2FY24",
            "news_id": "3dee1f7a-a767-4e2b-9004-7c07a5b67b63",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97eaffe1-a051-4e09-8eea-e06cb132b40e.pdf",
            "news_date": "2023-11-09 13:12:39",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to regulation 30 read with para A of schedule III of SEBI (LODR) Regulations, 2015, kindly find enclosed the transcript of the investors / analysts meet for Q1FY2024.The information is also available on the website of the Company.",
            "news_id": "1dae7b1c-48f7-4f94-ba5f-0659d275d15a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3172879-2d5d-49c3-afd1-20d98a85a37b.pdf",
            "news_date": "2023-08-22 14:13:47",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the aforesaid FinancialResults Conference Call is hosted on the website of the Company under the following link:http://marksanspharma.com/investors-meet.html",
            "news_id": "22398ec0-1540-4228-8284-2901425bc855",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39465d25-3902-47b5-8109-60ce8b0d318c.pdf",
            "news_date": "2023-08-17 09:20:56",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors presentation on Financial results for quarter ended June 30, 2023",
            "news_id": "3799c570-09d4-48c9-9459-1a8a3d36f096",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4db23e9-d535-4e51-be8f-6a2af3f7e549.pdf",
            "news_date": "2023-08-11 18:35:09",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Unaudited Consolidated And Standalone Financial Results For Quarter Ended June 30, 2023",
            "news_body": "Unaudited Consolidated and standalone financial results along with limited review reports for quarter ended June 30, 2023",
            "news_id": "84fbc614-0119-499d-b8f3-7e5a61e6439f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=291eed13-3d4c-4b83-96d8-eb4abda741e4.pdf",
            "news_date": "2023-08-11 18:30:45",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q4 FY23 Earnings Conference Call held on May 31, 2023",
            "news_id": "7a7ca194-e3ea-4a3d-a24a-a4639aedb9e0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=542f528d-dee0-4718-9ab9-10f1183f4f9e.pdf",
            "news_date": "2023-06-07 11:18:06",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Announcement Under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the aforesaid Financial Results Conference Call is hosted on the website of the Company under the following link: http://marksanspharma.com/investors-meet.html",
            "news_id": "738bb014-4bb2-4744-9f7c-32c54ee8cbf5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f2c2a18-0891-41b0-b835-cde464a3e869.pdf",
            "news_date": "2023-05-31 18:44:07",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q4FY23 and FY23",
            "news_id": "c21b1f26-fb75-43e4-8c2a-60e009a48386",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acb3439c-78f7-43a7-99aa-f0468efb43b3.pdf",
            "news_date": "2023-05-30 13:58:16",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2023 And Auditors Report Thereon.",
            "news_body": "Attached herewith Audited Financial Results for the quarter and financial year ended 31st March, 2023 and Auditors Report thereon.",
            "news_id": "c6cf303d-f626-4be1-8800-e5176195485c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6dbe92b-4375-44aa-aed4-e132a47caf4f.pdf",
            "news_date": "2023-05-30 13:50:56",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q3 FY23 Earnings Conference Call held on February 14, 2023",
            "news_id": "c918c8d5-c332-4e13-8d79-244ac4086382",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b694ba05-6daa-42eb-b291-b861dde45b28.pdf",
            "news_date": "2023-02-21 11:07:57",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the aforesaid Financial Results Conference Call is hosted on the website of the Company under the following link: http://marksanspharma.com/investors-meet.html",
            "news_id": "230f501b-d240-477e-a6ba-d1b6a6ea122e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4b1ede72-4b11-410d-bb2c-7fd55ea476be.pdf",
            "news_date": "2023-02-14 18:26:07",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q3FY23",
            "news_id": "bc337387-c6a4-4f46-a61f-11be9d1bfe01",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2eb5133-5eed-4357-9f94-caef44bf7a3b.pdf",
            "news_date": "2023-02-13 13:45:06",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2022 And Limited Review Report Thereon",
            "news_body": "In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Unaudited Financial Results (both Standalone and Consolidated) for the quarter and nine months ended 31st December, 2022 which have been approved by the Board of Directors at its meeting held today i.e. 13th February, 2023 along with Limited Review Reports given by statutory auditor of the Company.<BR>",
            "news_id": "04900a61-40a7-4ee8-9db0-05fdb2f16502",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c13c6d23-ca98-44b7-9882-031b0f02a57c.pdf",
            "news_date": "2023-02-13 13:40:24",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith disclosure of related party transactions for the half year ended 30th September, 2022.",
            "news_id": "b028c773-d888-44dc-ab8e-dc83b1e21e9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06a7de6a-63bd-4bc6-a819-1749b6dbf09b.pdf",
            "news_date": "2022-11-25 11:26:20",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q2 FY23 Earnings Conference Call held on November 16, 2022.",
            "news_id": "6038921f-3a47-4c84-8099-b1ca75a73a81",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=96366b09-0e35-4d56-910f-5f957c45d023.pdf",
            "news_date": "2022-11-21 17:12:04",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the Q2FY23 & H1FY23 Results Conference Call is hosted on the website of the Company under the following link: http://marksanspharma.com/investors-meet.htmI",
            "news_id": "3a2ffa24-6042-4bb5-9901-a640f2de69d8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=821b9ac6-2348-46a0-92c2-94e49519f3ba.pdf",
            "news_date": "2022-11-16 21:19:05",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation H1FY23 & Q2FY23",
            "news_id": "7163901f-3258-4653-9d4a-ed9dc0a19cae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5e2545e-8ce9-4408-9376-a20de7d72d48.pdf",
            "news_date": "2022-11-14 19:56:54",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half-Year Ended 30Th September, 2022 And Limited Review Report Thereon.",
            "news_body": "In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Unaudited Financial Results (both Standalone and Consolidated) for the quarter and half-year ended 30th September, 2022 which have been approved by the Board of Directors at its meeting held today i.e. 14th November, 2022 along with Limited Review Reports given by statutory auditor of the Company.<BR> <BR> The meeting commenced at 06:45 p.m. and concluded at 07:45 p.m.<BR>",
            "news_id": "0ee9717f-bb4e-4a9d-a7eb-d50927b9c44c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0587c961-88fc-4dfc-8f0c-ff85546e4f01.pdf",
            "news_date": "2022-11-14 19:49:12",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1FY23 Earnings Conference Call held on August 16, 2022.",
            "news_id": "14cce193-dc31-44c7-a1db-f92eb0175679",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22cfbd11-3572-4d9c-b28d-1fb15c52cc7c.pdf",
            "news_date": "2022-08-19 16:39:58",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q1FY23",
            "news_id": "66e4f33a-ea8d-48f6-83fb-11de78284e60",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed77e14b-16ce-4041-98da-f93cb2275822.pdf",
            "news_date": "2022-08-13 19:57:28",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th June, 2022 And Limited   Review Report Thereon",
            "news_body": "In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Unaudited Financial Results (both Standalone and Consolidated) for the quarter ended 30th June, 2022 which have been approved by the Board of Directors at its meeting held today i.e. 13th August, 2022 along with Limited Review Reports given by statutory auditor of the Company.<BR> <BR> The meeting commenced at 6:20 p.m. and concluded at 7:40 p.m.",
            "news_id": "dc08047b-4c92-4cfa-9364-806573091f09",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9882a73-6e6b-48b2-9ffb-e768a613dbbe.pdf",
            "news_date": "2022-08-13 19:55:45",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith disclosure of related party transactions of the Company and its subsidiaries for the half year ended 31st March, 2022.",
            "news_id": "98135a9e-2cf4-4c5e-89c0-bf59c49ef8eb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa3a3f46-19d6-4619-9d99-60fb65466e9a.pdf",
            "news_date": "2022-06-10 11:43:49",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q4 &FY22 Earnings Conference Call held on June 1, 2022.",
            "news_id": "4ba4f59d-3af5-4130-aa6d-085cd9b30097",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=36014887-210a-4f0d-b069-48aa626b5f58.pdf",
            "news_date": "2022-06-06 12:29:30",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q4&FY22 Results Conference Call is hosted on the website of the Company at http://marksanspharma.com/investors-meet.html",
            "news_id": "2959ae48-dfe4-4a87-a6bd-fc85b537954c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5582216-6d51-4337-ae21-4f3bdad10e87.pdf",
            "news_date": "2022-06-01 22:21:13",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q4 & FY22",
            "news_id": "f5b61553-e2ba-424b-beb2-2f8f5910076d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcdcfc07-efb0-4c30-afb4-f28f5492de2d.pdf",
            "news_date": "2022-05-30 20:15:21",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2022 And Auditors Report Thereon",
            "news_body": "In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Audited Financial Results (both Standalone and Consolidated) for the quarter and financial year ended 31st March, 2022 which have been approved by the Board of Directors at its meeting held today i.e. 30th May, 2022 along with Auditors Report thereon.<BR> <BR> The meeting commenced at 7:17 p.m. and concluded at 8:00 p.m.<BR> <BR> In this connection, we hereby confirm that the Statutory Auditors have given their reports on the Audited Annual Financial Results for the financial year ended 31st March, 2022 (both Standalone and Consolidated) with unmodified opinion.<BR> <BR> <BR>",
            "news_id": "192a40a1-aaac-4668-a1c2-385c9b142513",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22ad61a2-19b8-4743-a923-ace6f8deb41c.pdf",
            "news_date": "2022-05-30 20:11:40",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached an investors presentation of Marksans Pharma Limited for Q3 & 9M FY22.",
            "news_id": "10ee3702-60cc-411e-85f6-7a927d9044a2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1e9b58e-4350-43dd-814c-7619399583f1.pdf",
            "news_date": "2022-02-11 12:54:51",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Third Quarter Ended 31St December, 2021 And Limited Review Reports Thereon.",
            "news_body": "In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Unaudited Financial Results (both Standalone and Consolidated) for the third quarter ended 31st December, 2021 which have been approved by the Board of Directors at its meeting held today i.e. 11th February, 2022 along with Limited Review Reports given by Statutory auditor of the Company. <BR> The meeting commenced at 12:00 noon and concluded at 12:45 p.m.",
            "news_id": "336f3775-ff78-4844-b2b6-fa2b18335427",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=36ae1a76-804c-475a-8651-dfad1ade2ca8.pdf",
            "news_date": "2022-02-11 12:52:40",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached an investors presentation of Marksans Pharma Limited for Q2 & H1 FY22.",
            "news_id": "154bfe9f-31d8-46a5-8b58-51c2ae337e4d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b438d166-1877-44a3-920c-4ff0316d2195.pdf",
            "news_date": "2021-11-10 10:59:38",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half-Year Ended 30Th September, 2021 And Limited Review Reports Thereon",
            "news_body": "In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Unaudited Financial Results (both Standalone and Consolidated) for the quarter and half-year ended 30th September, 2021 which have been approved by the Board of Directors at its meeting held today i.e. 10th November, 2021 along with Limited Review Reports given by statutory auditor of the Company.<BR> <BR> The meeting commenced at 9:30 a.m. and concluded at 10:50 a.m.",
            "news_id": "90b4241b-9f8a-4556-af6a-9dd61f9b84b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a8bd4f7-b44e-44a1-9a36-949f105982f5.pdf",
            "news_date": "2021-11-10 10:56:00",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached an investors presentation of Marksans Pharma Limited for Q1 FY22.",
            "news_id": "8712842a-5b1b-4729-a8d6-9fffb1c8021e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=035cffb9-ca8c-4dee-864a-dd2b94f8a675.pdf",
            "news_date": "2021-08-11 12:22:21",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th June, 2021 And Limited Review Reports Thereon.",
            "news_body": "In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Unaudited Financial Results (both Standalone and Consolidated) for the quarter ended 30th June, 2021 approved by the Board of Directors at its meeting held today i.e. 11th August, 2021 along with Limited Review Reports given by statutory auditor of the Company.<BR> <BR> The meeting commenced at 11:00 a.m. and concluded at 12:10 p.m.",
            "news_id": "987578d3-72e4-41e7-aa88-42d1fe11646f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d788ff3d-8178-4869-bfd6-72e90c988039.pdf",
            "news_date": "2021-08-11 12:14:37",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2021",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith disclosures of related party transactions for the half year ended 31st March, 2021. The financial results for the quarter and year ended 31st March, 2021 both standalone and consolidated were published on 31st May, 2021.",
            "news_id": "11f5e015-06f2-445d-9359-6008b5feaa81",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc0ed3b1-146f-49be-9f23-92eede0a633e.pdf",
            "news_date": "2021-06-28 12:36:57",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Attached pl find Investors Presentation for the year ended 31st March, 2021",
            "news_id": "a367f6ab-7e1a-46d3-9ba9-1758ab983c50",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4bdc92a-4808-4723-baba-52800867f762.pdf",
            "news_date": "2021-05-31 12:43:04",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MARKSANS",
            "disp": "Marksans Pharma",
            "bse_code": 524404,
            "isin": "INE750C01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2021 And Auditors Report Thereon.",
            "news_body": "In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Audited Financial Results (both Standalone and Consolidated) for the quarter and financial year ended 31st March, 2021 approved by the Board of Directors at its meeting held today i.e. 31st May, 2021 along with Auditors Report thereon.<BR> <BR> The meeting commenced at 11:00 a.m. and concluded at 12:25 p.m.   <BR> <BR> In this connection, we hereby confirm that the Statutory Auditors have given their reports on the Audited Annual Financial Results for the financial year ended 31st March, 2021 (both Standalone and Consolidated) with unmodified opinion.",
            "news_id": "f966506f-e05f-4f1a-ac22-39d7f125e515",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f844cd88-2a8f-436c-8171-f4dd798c36a7.pdf",
            "news_date": "2021-05-31 12:35:09",
            "seo": "marksans-pharma-ltd",
            "ltp": 187.54,
            "ch": 0.549999999999983,
            "pch": 0.29413337611636076,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 10579,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}